Adaptive isotonic estimation of the minimum effective and peak doses in the presence of covariates

DOI10.17615/S915-6112zbMATH Open1237.62175OpenAlexW4299660783WikidataQ36033877 ScholiaQ36033877MaRDI QIDQ419309FDOQ419309

Authors: Changfu Xiao, Anastasia Ivanova 

Publication date: 18 May 2012

Published in: Journal of Statistical Planning and Inference (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.17615/s915-6112

Recommendations

• Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpoint
• A hybrid method to estimate the minimum effective dose for monotone and non-monotone dose-response relationships
• Response-adaptive dose-finding under model uncertainty
• Information-regret compromise in covariate-adaptive treatment allocation
• Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates

zbMATH Keywords

up-and-down designsdose-rangingphase II trials

Mathematics Subject Classification ID

Estimation in survival analysis and censored data (62N02) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)

Cites Work

• A Simplex Method for Function Minimization
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• Constrained Statistical Inference
• Title not available (Why is that?)
• Title not available (Why is that?)
• Title not available (Why is that?)
• Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach
• Simple Sequential Boundaries for Treatment Selection in Multi‐Armed Randomized Clinical Trials with a Control
• Continual reassessment method for ordered groups
• Combining Multiple Comparisons and Modeling Techniques in Dose‐Response Studies
• Confidence interval estimation subject to order restrictions
• Optimal Bayesian-feasible dose escalation for cancer phase I trials
• Dose finding using the biased coin up-and-down design and isotonic regression
• Designs for Single- or Multiple-Agent Phase I Trials
• Monitoring late-onset toxicities in phase I trials using predicted risks
• Title not available (Why is that?)

Cited In (1)

• A novel framework to estimate multidimensional minimum effective doses using asymmetric posterior gain and \(\epsilon\)-tapering

This page was built for publication: Adaptive isotonic estimation of the minimum effective and peak doses in the presence of covariates

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q419309)